Aytu BioPharma (AYTU)
(Delayed Data from NSDQ)
$2.85 USD
+0.03 (1.06%)
Updated Jul 18, 2024 03:59 PM ET
After-Market: $2.85 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 28% (69 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | NA | 2.87 | 61.00 |
Year Ago Quarter Estimate | NA | -5.36 | 54.84 |
Next Quarter Estimate | NA | 7.43 | 63.00 |
Next Year Estimate | NA | 29.71 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | NA | NA |
Next Year | NA | NA | NA |
Last 5 Years | NA | NA | NA |
Next 5 Years | NA | NA | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 0.52 | 2.16 |
Price/Cash Flow (MRFY) | 2.89 | 16.71 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -14.60% | -100.57% |
Return on Equity (TTM) | -31.31% | -49.27% |
Debt to Equity (MRQ) | NA | 0.13 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.